Inhibition of C3 with APL-2 in autoimmune hemolytic anemia to reduce hemolysis

Описание к видео Inhibition of C3 with APL-2 in autoimmune hemolytic anemia to reduce hemolysis

Bruno Fattizzo, MD, of the University of Milan, Milan, Italy, speaks at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK. He discusses his research on the effects of pegcetacoplan, a C3 inhibitor, on hemolysis in autoimmune hemolytic anemia (AIHA).

Комментарии

Информация по комментариям в разработке